Načítá se...

Cancer neoantigens as potential targets for immunotherapy

Immune checkpoint inhibitors (ICIs) targeting the cytotoxic T-lymphocyte-associated protein-4 (CTLA-4) and programed cell death protein 1 (PD-1) or its ligand PD-L1 have increased the survival and cure rates for patients with many cancer types in various disease settings. However, only 10–40% of can...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Exp Metastasis
Hlavní autoři: Ma, Weijie, Pham, Brian, Li, Tianhong
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Netherlands 2021
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8097110/
https://ncbi.nlm.nih.gov/pubmed/33950415
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10585-021-10091-1
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!